Core Viewpoint - The collaboration between Uber, Lyft, and Baidu marks a significant step in the global expansion of domestic Robotaxi operators, with plans to test autonomous taxis in the UK by mid-2026 using Baidu's Apollo Go RT6 model [2][3][8]. Group 1: Industry Developments - The partnership with Uber and Lyft allows domestic Robotaxi operators to leverage L4 autonomous driving technology for global market expansion [3][9]. - Companies like Pony.ai and WeRide have already begun international operations, with Pony.ai partnering with local transport services in the Middle East [3][10]. - The successful deployment of over a thousand vehicles in cities like Wuhan and Abu Dhabi has led to positive financial outcomes for leading operators, achieving unit economics (UE) profitability [4][10]. Group 2: Financial Performance and Projections - Major players in the Robotaxi sector are achieving profitability on a per-vehicle basis, with significant reductions in vehicle costs contributing to this trend [4][11]. - Pony.ai's seventh-generation Robotaxi has seen a cost reduction of over 70% compared to previous models, with further reductions expected by 2026 [4][11]. - The expansion of fleets and the alleviation of operational pressures are anticipated to drive growth in the Robotaxi market in 2026 [4][11]. Group 3: Investment Recommendations - The acceleration of international expansion by domestic Robotaxi operators is expected to lead to rapid fleet growth in 2026, with a positive outlook for operators and related supply chain companies [5][11]. - Specific stocks to watch include XPeng Motors, Desay SV, Huayang Group, Bertel, Joyson Electronics, Pony.ai, Horizon Robotics, Nexperia, and Top Group [5][12].

Group 1 - The Dow futures rose by 0.08%, S&P 500 futures increased by 0.27%, and Nasdaq futures gained 0.44% [1] - Spot gold surpassed $4,400 per ounce for the first time, rising over 1.5% to $4,407 per ounce, marking a nearly 68% increase year-to-date [1] - Gold mining stocks saw significant pre-market gains, with Sibanye Stillwater up 3.5%, AngloGold Ashanti up 4.2%, and Newmont Mining up 2.5% [1] Group 2 - Semiconductor stocks mostly rose in pre-market trading, with Micron Technology up about 3%, and AMD, Nvidia, TSMC, and Intel each up around 1% [2] - Uber announced a partnership with Baidu to conduct trials of autonomous taxis in London, with plans to launch a pilot project using Baidu's Apollo Go RT6 by mid-2026 [2] - Italy's competition authority fined Apple nearly €98.6 million for abusing its market dominance related to its "App Tracking Transparency" policy [2] Group 3 - Medtronic's diabetes business, MiniMed, filed for an IPO to raise up to $100 million [3] - GlaxoSmithKline's new drug was approved in China for the treatment of chronic obstructive pulmonary disease (COPD) in adults [3] - A Starlink satellite from SpaceX experienced an anomaly, descending 4,000 meters in orbit, potentially threatening other satellites [3] Group 4 - Cleveland Fed President Beth Hammack indicated that the Federal Reserve does not need to change the current benchmark interest rate range of 3.5% to 3.75% before spring 2026 [4]

Group 1 - The Dow futures rose by 0.08%, S&P 500 futures increased by 0.27%, and Nasdaq futures gained 0.44% [1] - Spot gold surpassed $4400 per ounce for the first time, rising over 1.5% to $4407 per ounce, marking a nearly 68% increase this year. Gold mining stocks saw significant pre-market gains, with Sibanye Stillwater up 3.5%, AngloGold Ashanti up 4.2%, and Newmont Mining up 2.5% [1] - Semiconductor stocks mostly rose in pre-market trading, with Micron Technology up about 3%, and AMD, Nvidia, TSMC, and Intel each up around 1% [1] Group 2 - Uber announced a partnership with Baidu to conduct autonomous taxi trials in London, aiming to launch a pilot project using Baidu's Apollo Go RT6 by mid-2026, with official operations expected by the end of next year. Uber's stock rose over 1% in pre-market trading [1] - The Italian Competition Authority fined Apple nearly €98.6 million for abusing market dominance, citing the restrictive nature of Apple's "App Tracking Transparency" policy [2] - Medtronic's diabetes business, MiniMed, submitted an IPO application to raise up to $100 million, focusing on diabetes management devices and technologies [2] - GlaxoSmithKline's new drug was approved in China for the treatment of chronic obstructive pulmonary disease (COPD) in adults with elevated eosinophils [2]